logo
APIX Biosciences NV announces new advances in Honeybee Nutrition

APIX Biosciences NV announces new advances in Honeybee Nutrition

Toronto Stara day ago
WINGENE, Belgium, Aug. 20, 2025 (GLOBE NEWSWIRE) — Belgian agri-technology company APIX Biosciences NV, active in Europe and the United States, proudly announces the publication in Nature, by APIX Biosciences' Scientific Founder Prof. Geraldine Wright and her team, on the production of plant-sterols in a yeast synthetic biology platform and the role of these phytosterols in honeybee nutrition (https://doi.org/10.1038/s41586-025-09431-y). APIX is pleased to have acquired and integrated this technology in its portfolio of technologies.
'Sterols are one of many nutrient classes honeybees require in their diet. This publication describes how to genetically engineer yeast to make phytosterols. Experiments feeding these yeasts to honeybees shows that the presence of these sterols can improve their reproduction,' says APIX Biosciences' Chairman Thierry Bogaert. 'This confirms and extends the work that APIX Biosciences NV published last May in the Proceedings of the Royal Society B using these phytosterols produced through chemical synthesis (https://doi.org/10.1098/rspb.2024.3078)'.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

APIX Biosciences NV announces new advances in Honeybee Nutrition
APIX Biosciences NV announces new advances in Honeybee Nutrition

Toronto Star

timea day ago

  • Toronto Star

APIX Biosciences NV announces new advances in Honeybee Nutrition

WINGENE, Belgium, Aug. 20, 2025 (GLOBE NEWSWIRE) — Belgian agri-technology company APIX Biosciences NV, active in Europe and the United States, proudly announces the publication in Nature, by APIX Biosciences' Scientific Founder Prof. Geraldine Wright and her team, on the production of plant-sterols in a yeast synthetic biology platform and the role of these phytosterols in honeybee nutrition ( APIX is pleased to have acquired and integrated this technology in its portfolio of technologies. 'Sterols are one of many nutrient classes honeybees require in their diet. This publication describes how to genetically engineer yeast to make phytosterols. Experiments feeding these yeasts to honeybees shows that the presence of these sterols can improve their reproduction,' says APIX Biosciences' Chairman Thierry Bogaert. 'This confirms and extends the work that APIX Biosciences NV published last May in the Proceedings of the Royal Society B using these phytosterols produced through chemical synthesis (

The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research
The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research

Toronto Star

time2 days ago

  • Toronto Star

The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research

Philadelphia, PA, Aug. 19, 2025 (GLOBE NEWSWIRE) — The Wistar Institute announces the National Institutes of Health (NIH) granted a five-year, $17 million research award to launch iCure Consortium to develop individualized 'cure regimens' for HIV. The Wistar-led, iCure Consortium's objective is to advance strategies to cure HIV through tailored personalized medicine. 'Today 38 million people still live with HIV worldwide, and 1.3 million contract the virus each year,' said Luis J. Montaner, D.V.M., iCure principal investigator, executive vice president of The Wistar Institute and director of Wistar's HIV Cure and Viral Diseases Center. 'For the first time, this grant brings our best team together working towards a cure tailored to each participant by pairing the latest in neutralizing antibody and cell-therapy breakthroughs against the unique, person-specific features of HIV.'

BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic's IzoView Device
BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic's IzoView Device

Toronto Star

time2 days ago

  • Toronto Star

BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic's IzoView Device

VANCOUVER, British Columbia, and SACRAMENTO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ('Izotropic', or the 'Company'), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the launch of a new online platform supporting the Company's awareness initiatives. has been created as a central educational resource on dedicated breast CT technology and the Company's IzoView Breast CT Imaging System, with a focus on its potential to address persistent challenges in detecting breast cancer in the 50% of women with dense breast tissue. With IzoView's engineering complete, the site is designed to evolve alongside the Company through clinical study preparation, U.S. and global regulatory phases, and ongoing education and awareness initiatives leading to commercial launch.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store